These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 27298335)

  • 41. L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer.
    Nau MM; Brooks BJ; Battey J; Sausville E; Gazdar AF; Kirsch IR; McBride OW; Bertness V; Hollis GF; Minna JD
    Nature; 1985 Nov 7-13; 318(6041):69-73. PubMed ID: 2997622
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MYC Family Amplification Dictates Sensitivity to BET Bromodomain Protein Inhibitor Mivebresib (ABBV075) in Small-Cell Lung Cancer.
    Plotnik JP; Zha Z; Feng W; Lee I; Riehm J; McClure RA; Sandoval S; Uziel T; Murphy E; Lu X; Lam LT
    Mol Cancer Res; 2024 Aug; 22(8):689-698. PubMed ID: 38747975
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human small-cell lung cancers show amplification and expression of the N-myc gene.
    Nau MM; Brooks BJ; Carney DN; Gazdar AF; Battey JF; Sausville EA; Minna JD
    Proc Natl Acad Sci U S A; 1986 Feb; 83(4):1092-6. PubMed ID: 2869482
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Barasertib (AZD1152), a Small Molecule Aurora B Inhibitor, Inhibits the Growth of SCLC Cell Lines In Vitro and In Vivo.
    Helfrich BA; Kim J; Gao D; Chan DC; Zhang Z; Tan AC; Bunn PA
    Mol Cancer Ther; 2016 Oct; 15(10):2314-2322. PubMed ID: 27496133
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MYC, MYCL, and MYCN as therapeutic targets in lung cancer.
    Massó-Vallés D; Beaulieu ME; Soucek L
    Expert Opin Ther Targets; 2020 Feb; 24(2):101-114. PubMed ID: 32003251
    [No Abstract]   [Full Text] [Related]  

  • 46. Dysregulated Ribosome Biogenesis Reveals Therapeutic Liabilities in Cancer.
    Bursać S; Prodan Y; Pullen N; Bartek J; Volarević S
    Trends Cancer; 2021 Jan; 7(1):57-76. PubMed ID: 32948502
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Analysis of the activation of the myc family oncogene and of its stability over time in xenografted human lung carcinomas.
    Gazzeri S; Brambilla E; Chauvin C; Jacrot M; Benabid AL; Brambilla C
    Cancer Res; 1990 Mar; 50(5):1566-70. PubMed ID: 2154327
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of DHODH as a therapeutic target in small cell lung cancer.
    Li L; Ng SR; Colón CI; Drapkin BJ; Hsu PP; Li Z; Nabel CS; Lewis CA; Romero R; Mercer KL; Bhutkar A; Phat S; Myers DT; Muzumdar MD; Westcott PMK; Beytagh MC; Farago AF; Vander Heiden MG; Dyson NJ; Jacks T
    Sci Transl Med; 2019 Nov; 11(517):. PubMed ID: 31694929
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeting NOTCH activation in small cell lung cancer through LSD1 inhibition.
    Augert A; Eastwood E; Ibrahim AH; Wu N; Grunblatt E; Basom R; Liggitt D; Eaton KD; Martins R; Poirier JT; Rudin CM; Milletti F; Cheng WY; Mack F; MacPherson D
    Sci Signal; 2019 Feb; 12(567):. PubMed ID: 30723171
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transcription Factor NFIB Is a Driver of Small Cell Lung Cancer Progression in Mice and Marks Metastatic Disease in Patients.
    Semenova EA; Kwon MC; Monkhorst K; Song JY; Bhaskaran R; Krijgsman O; Kuilman T; Peters D; Buikhuisen WA; Smit EF; Pritchard C; Cozijnsen M; van der Vliet J; Zevenhoven J; Lambooij JP; Proost N; van Montfort E; Velds A; Huijbers IJ; Berns A
    Cell Rep; 2016 Jul; 16(3):631-43. PubMed ID: 27373156
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeting RNA polymerase I with an oral small molecule CX-5461 inhibits ribosomal RNA synthesis and solid tumor growth.
    Drygin D; Lin A; Bliesath J; Ho CB; O'Brien SE; Proffitt C; Omori M; Haddach M; Schwaebe MK; Siddiqui-Jain A; Streiner N; Quin JE; Sanij E; Bywater MJ; Hannan RD; Ryckman D; Anderes K; Rice WG
    Cancer Res; 2011 Feb; 71(4):1418-30. PubMed ID: 21159662
    [TBL] [Abstract][Full Text] [Related]  

  • 52. c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I.
    Grandori C; Gomez-Roman N; Felton-Edkins ZA; Ngouenet C; Galloway DA; Eisenman RN; White RJ
    Nat Cell Biol; 2005 Mar; 7(3):311-8. PubMed ID: 15723054
    [TBL] [Abstract][Full Text] [Related]  

  • 53.
    Voigt E; Wallenburg M; Wollenzien H; Thompson E; Kumar K; Feiner J; McNally M; Friesen H; Mukherjee M; Afeworki Y; Kareta MS
    Mol Cancer Res; 2021 Dec; 19(12):2015-2025. PubMed ID: 34593608
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression and amplification of myc gene family in small cell lung cancer and its relation to biological characteristics.
    Takahashi T; Obata Y; Sekido Y; Hida T; Ueda R; Watanabe H; Ariyoshi Y; Sugiura T; Takahashi T
    Cancer Res; 1989 May; 49(10):2683-8. PubMed ID: 2540905
    [TBL] [Abstract][Full Text] [Related]  

  • 55. NFIB overexpression cooperates with Rb/p53 deletion to promote small cell lung cancer.
    Wu N; Jia D; Ibrahim AH; Bachurski CJ; Gronostajski RM; MacPherson D
    Oncotarget; 2016 Sep; 7(36):57514-57524. PubMed ID: 27613844
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Myc manipulates the miRNA content and biologic functions of small cell lung cancer cell-derived small extracellular vesicles.
    Tokgün O; İnci K
    Mol Biol Rep; 2022 Aug; 49(8):7953-7965. PubMed ID: 35690961
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Complicated mechanisms of class II transactivator transcription deficiency in small cell lung cancer and neuroblastoma.
    Yazawa T; Ito T; Kamma H; Suzuki T; Okudela K; Hayashi H; Horiguchi H; Ogata T; Mitsui H; Ikeda M; Kitamura H
    Am J Pathol; 2002 Jul; 161(1):291-300. PubMed ID: 12107114
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification and Targeting of Long-Term Tumor-Propagating Cells in Small Cell Lung Cancer.
    Jahchan NS; Lim JS; Bola B; Morris K; Seitz G; Tran KQ; Xu L; Trapani F; Morrow CJ; Cristea S; Coles GL; Yang D; Vaka D; Kareta MS; George J; Mazur PK; Nguyen T; Anderson WC; Dylla SJ; Blackhall F; Peifer M; Dive C; Sage J
    Cell Rep; 2016 Jul; 16(3):644-56. PubMed ID: 27373157
    [TBL] [Abstract][Full Text] [Related]  

  • 59. c-Myc suppresses the tumorigenicity of lung cancer cells and down-regulates vascular endothelial growth factor expression.
    Barr LF; Campbell SE; Diette GB; Gabrielson EW; Kim S; Shim H; Dang CV
    Cancer Res; 2000 Jan; 60(1):143-9. PubMed ID: 10646866
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Kdm1a promotes SCLC progression by transcriptionally silencing the tumor suppressor Rest.
    Jin Y; Ma D; Gramyk T; Guo C; Fang R; Ji H; Shi YG
    Biochem Biophys Res Commun; 2019 Jul; 515(1):214-221. PubMed ID: 31146914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.